<DOC>
	<DOC>NCT00605085</DOC>
	<brief_summary>The objective is to investigate the safety and tolerability of Japanese Encephalitis vaccine IC51 with an inactive control in healthy subjects aged &gt; or = 18 years</brief_summary>
	<brief_title>Safety and Tolerability of the Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 years of age Written informed consent obtained prior to study entry Use of any other investigational or nonregistered drug or vaccine in addition to the study vaccine during the study period or within 30 days preceding the first dose of study vaccine History of any previous JE vaccination (e.g. JEVAXÂ®) Immunodeficiency including postorgantransplantation or immunosuppressive therapy A family history of congenital or hereditary immunodeficiency History of autoimmune disease Any acute infections within 2 weeks prior to enrollment Known or suspected HIV Infection Pregnancy, lactation or unreliable contraception in female subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>